ArticlePloS one2026
Serological evidence of West Nile virus circulation in Indonesia: Initial insights into an underrecognized flavivirus threat.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) is a mosquito-borne flavivirus primarily transmitted by Culex species and maintained in a bird-mosquito-bird cycle. Though WNV is not considered endemic to Indonesia, sporadic molecular and serological findings suggest possible under-recognized circulation. To examine this possibility, we conducted a cross-sectional serosurvey of 569 archived serum and plasma samples collected between 2021 and 2023 from non-febrile individuals, including blood donors in Papua and community-based participants in Kalimantan. Samples were initially screened using a commercial WNV IgM Enzyme Linked Immunosorbent Assay (ELISA), IgM-positive and equivocal samples were further tested with IgM ELISAs against closely related flaviviruses, including dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV). WNV-reactive IgM was initially detected in 9 (1.58%) samples, with 7 (1.23%) additional equivocal results. After additional testing, the WNV IgM seroprevalence was 0.35%, while 1.76% showed cross-reactivity to other flaviviruses. These cases spanned regions including North Kalimantan and Papua, where evidence of WNV-related exposure was previously reported. Detection of WNV-reactive IgM in asymptomatic individuals suggests potential silent or undetected circulation of WNV in Indonesia. Given diagnostic cross-reactivity and IgM persistence, further studies using molecular tools, plaque reduction neutralization test (PRNT), IgG testing, and entomological data are needed to clarify WNV epidemiology and inform surveillance strategies in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.